FDA seeks ‘legislative solution’ for LDT oversight
Regulatory NewsMichael Mezher
Diagnostics/IVDsMedical DevicesNorth AmericaRegulatory Intelligence/PolicyRegulatory NewsMichael MezherDiagnostics/IVDsMedical DevicesNorth AmericaRegulatory Intelligence/Policy